brassinolide

Subscribe to Selected New Research on brassinolide

14 relevant articles (0 outcomes, 1 trials/studies) found for this Bio-Agent

Description: plant growth promoting steroidal lactone from rape pollen; RN given refers to (2alpha,3alpha,5alpha,22R,23R,24S)-isomer; structure in first source

Also Known As:

24-epibrassinolide; 2alpha,3alpha,22alpha,23alpha-tetrahydroxy-24alpha-methyl-B-homo-7-oxa-5alpha-cholestan-6-one; brassinolide, (2alpha,3alpha,5alpha,22S,23S)-isomer; brassinolide, (2alpha,3alpha,5alpha.22R,23R)-isomer; B-Homo-7-oxaergostan-6-one, 2,3,22,23-tetrahydroxy-, (2alpha,3alpha,5alpha,22R,23R,24S)-

Bio-Agent Context: Research Results

Polycyclic Compounds: 58

Heterocyclic Steroids

brassinolide: 14

Experts

1.	Wu, Yao-Dong: 1 article (05/2007)
2.	Lou, Yi-Jia: 1 article (05/2007)
3.	Guo, Shi-Rong: 1 article (10/2006)
4.	Kang, Yun-Yan: 1 article (10/2006)
5.	Duan, Jiu-Ju: 1 article (10/2006)
6.	Hu, Xiao-Hui: 1 article (10/2006)
7.	Shono, Mariko: 1 article (02/2003)
8.	Singh, Ishwar: 1 article (02/2003)

Related Diseases

1.	Prostatic Neoplasms (Prostate Cancer) 05/01/2007 - "The present study was carried out to investigate the effect of brassinolide on androgen-independent human prostate cancer PC-3 cell viability" 05/01/2007 - "Brassinolide might therefore be a promising candidate for the treatment of prostate cancer." 05/01/2007 - "Brassinolide, a plant sterol from pollen of Brassica napus L., induces apoptosis in human prostate cancer PC-3 cells." 01/01/2008 - "Therefore, in our next series of experiments, we tested the effects of the most promising and readily available BR analogues with interesting anticancer properties, 28-homocastasterone (1) and 24-epibrassinolide (2), on the viability, proliferation, and cycling of hormone-sensitive/insensitive (MCF-7/MDA-MB-468) breast and (LNCaP/DU-145) prostate cancer cell lines to determine whether the discovered cytotoxic activity of BRs could be, at least partially, related to brassinosteroid-nuclear receptor interactions" Order ALL the reference details at left...
2.	Dwarfism 06/05/2002 - "The compound-induced hypocotyl dwarfism was restored by the coapplication of 10 nM brassinolide but not by 1 microM gibberellin" 09/01/2001 - "These changes included dwarfism with altered leaf morphology, including downward curling and dark-green color, and the changes were reversed by brassinolide" 06/01/2001 - "Transgenic plants with reduced Pra2 exhibit a dark-specific dwarfism, which is completely rescued by exogenous brassinolide" 02/01/1998 - "Dwarfism could be rescued by the application of brassinolide, suggesting that DWF4 plays a role in brassinosteroid (BR) biosynthesis" 05/01/2000 - "Brassinazole-treated cress also showed dwarfism, with altered leaf morphology, including the downward curling and dark green color typical of Arabidopsis BR-deficient mutants, and this dwarfism was reversed by the application of 10 nM brassinolide" Order ALL the reference details at left...
3.	Heat Stress Disorders (Heat Stress) 02/01/2003 - "Effect of 24-epibrassinolide on pollen viability during heat-stress in tomato." Order ALL the reference details at left...
4.	Rupture 09/01/2001 - "Brassinolide and GA4 promoted endosperm rupture of dark-imbibed non-photodormant seeds, but only GA4 enhanced betaGLU I induction" 09/01/2001 - "Brassinolide, but not GA4, accelerated endosperm rupture of tobacco seeds imbibed in the light" Order ALL the reference details at left...
5.	Neoplasms (Cancer) 07/10/2008 - "Cytotoxicity of the products was studied using human normal and cancer cell lines with 28-homocastasterone as positive control and their brassinolide type activity was established using the bean second-internode test with 24-epibrassinolide as standard" Order ALL the reference details at left...

Related Drugs and Biologics

1.	brassinolide
2.	Phosphotransferases (Kinase)
3.	Hormones
4.	Enzymes
5.	6-deoxocathasterone
6.	brassinazole
7.	campesterol
8.	campestanol

Best Treatments:
Research Summary Report
on Prostatic Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 1549 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>